Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial???Lipid Lowering Arm (ASCOT-LLA)

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Drugs

Topics

Engineering

Pathology

Medicine

Internal Medicine

Cardiology

Show all topics

DOI

10.2165/00003495-200464002-00005